These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10083576)

  • 21. Thymoglobulin versus basiliximab induction therapy for simultaneous kidney-pancreas transplantation: impact on rejection, graft function, and long-term outcome.
    Bazerbachi F; Selzner M; Boehnert MU; Marquez MA; Norgate A; McGilvray ID; Schiff J; Cattral MS
    Transplantation; 2011 Nov; 92(9):1039-43. PubMed ID: 22002345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective, randomized, open-label study of steroid withdrawal in pancreas transplantation-a preliminary report with 6-month follow-up.
    Gruessner RW; Sutherland DE; Parr E; Humar A; Gruessner AC
    Transplant Proc; 2001; 33(1-2):1663-4. PubMed ID: 11267460
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation.
    Gruessner RW; Kandaswamy R; Humar A; Gruessner AC; Sutherland DE
    Transplantation; 2005 May; 79(9):1184-9. PubMed ID: 15880067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low incidence of rejection after synchronous pancreas-kidney transplantation with Neoral.
    Cattral MS; Hemming AW; Greig PD; Rowsell C; Chari R; Wright E; Donat D; Cole E; Levy GA
    Transplant Proc; 1998 Aug; 30(5):1946. PubMed ID: 9723346
    [No Abstract]   [Full Text] [Related]  

  • 25. Eosinophiluria as an indicator of kidney-pancreas transplant rejection.
    Zamora J; Korb S; Bentt L; Allston C; Jonsson J; Currier C; Light JA
    Transplant Proc; 1993 Feb; 25(1 Pt 2):948-50. PubMed ID: 8442276
    [No Abstract]   [Full Text] [Related]  

  • 26. Simultaneous pancreas-kidney transplantation: five-year results from a single center.
    Martins L; Pedroso S; Henriques AC; Dias L; Sarmento AM; Seca R; Oliveira F; Dores J; Lhamas A; Coelho T; Ribeiro A; Esteves S; Pereira R; Almeida R; Amil M; Cabrita A; Teixeira M
    Transplant Proc; 2006; 38(6):1929-32. PubMed ID: 16908326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of cause of graft loss (rejection or technical) on patient survival after failed pancreas transplantation.
    Moudry-Munns K; Gruessner A; Gruessner R; Sutherland DE
    Transplant Proc; 1994 Apr; 26(2):427. PubMed ID: 8171486
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk factors of long-term survivals in combined kidney/pancreas transplantation: a multivariate analysis of 259 recipients.
    Tso PL; Elkhammas EA; Henry ML; Kim SI; Davies EA; Bumgardner GL; Ferguson RM
    Transplant Proc; 1995 Dec; 27(6):3104. PubMed ID: 8539865
    [No Abstract]   [Full Text] [Related]  

  • 29. Evolution of combined kidney/pancreas transplantation in a single center.
    Henry ML; Elkhammas EA; Tesi RJ; Ferguson RM
    Transplant Proc; 1994 Apr; 26(2):419. PubMed ID: 8171482
    [No Abstract]   [Full Text] [Related]  

  • 30. Steroid-resistant acute rejection following SPK: importance of maintaining therapeutic dosing in a triple-drug regimen.
    Burke GW; Ciancio G; Figueiro J; Olson L; Gomez C; Rosen A; Suzart K; Miller J
    Transplant Proc; 2002 Aug; 34(5):1918-9. PubMed ID: 12176628
    [No Abstract]   [Full Text] [Related]  

  • 31. Preemptive combined pancreas-kidney transplantation: is earlier better?
    Stratta RJ; Taylor RJ; Lowell JA; Bynon JS; Cattral MS; Brennan DC; Weide LG; Duckworth WC
    Transplant Proc; 1994 Apr; 26(2):422-4. PubMed ID: 8171484
    [No Abstract]   [Full Text] [Related]  

  • 32. Simultaneous pancreas-kidney transplantation at the University of Pittsburgh.
    Shapiro R; Jordan ML; Scantlebury VP; Vivas CA; Jain A; Chakrabarti P; McCauley J; Johnston J; Randhawa P; Rao A; Fung JJ; Corry RJ
    Clin Transpl; 1999; ():217-21. PubMed ID: 11038640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retransplantation in the diabetic with a pancreas allograft after previous kidney or pancreas transplant.
    Stratta RJ; Sindhi R; Taylor RJ; Lowell JA; Sudan D; Castaldo P; Gill IS; Jerius JT
    Transplant Proc; 1997; 29(1-2):666. PubMed ID: 9123469
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term kidney and pancreas function with tacrolimus immunosuppression following simultaneous kidney and pancreas transplantation.
    Peddi VR; Munda R; Demmy AM; Alexander JW; First MR
    Transplant Proc; 1998 Jun; 30(4):1541-3. PubMed ID: 9636626
    [No Abstract]   [Full Text] [Related]  

  • 35. Discordant graft loss from rejection of organs from the same donor in simultaneous pancreas-kidney recipients.
    Sutherland DE; Gruessner R; Moudry-Munns K; Gruessner A
    Transplant Proc; 1995 Feb; 27(1):907-8. PubMed ID: 7879225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporin monotherapy in pancreaticorenal transplantation.
    Ward RG; Gecim E; Bone JM; Bakran A; Sells RA
    Transplant Proc; 1994 Apr; 26(2):548. PubMed ID: 8171547
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of a donor quality score on pancreas transplant survival in the Eurotransplant area.
    Vinkers MT; Rahmel AO; Slot MC; Smits JM; Schareck WD
    Transplant Proc; 2008 Dec; 40(10):3606-8. PubMed ID: 19100449
    [No Abstract]   [Full Text] [Related]  

  • 38. Morbidity, mortality, and long-term allograft function in kidney transplantation alone and simultaneous pancreas-kidney in diabetic patients.
    Basadonna GP; Arrazola L; Matas AJ; Gruessner R; Schmidt W; Sutherland DE
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1321-2. PubMed ID: 8442128
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of pretransplant cytomegalovirus serology and treatment of rejection upon disease after kidney and kidney plus pancreas transplantation.
    Mayoral JL; Brayman KL; Gillingham KJ; Sutherland DE; Najarian JS; Dunn DL
    Transplant Proc; 1992 Jun; 24(3):929-31. PubMed ID: 1318594
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk factors and outcomes analyses at 36 months of a prospective, randomized, multicenter, trial of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
    Stratta RJ; Alloway RR; Lo A; Hodge EE
    Transplant Proc; 2005 Oct; 37(8):3527-30. PubMed ID: 16298650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.